Peter S. Nelson

65.8k citations

420 papers · 32.9k indexed · 12 hit papers · h-index 85

Cancer Research top 0.02%
- Cancer, Lipids, and Metabolism 46
- Cancer Genomics and Diagnostics 32
Pulmonary and Respiratory Medicine top 0.02%
- Prostate Cancer Treatment and Research 283
- Prostate Cancer Diagnosis and Treatment 67
Molecular Biology top 0.1%
- Molecular Biology Techniques and Applications 35
- Cancer-related gene regulation 28
Oncology top 0.2%
Endocrinology, Diabetes and Metabolism top 0.2%
- Hormonal and reproductive studies 52
Genetics
- Estrogen and related hormone effects 29

Co-authors: Robert L. Vessella Elahe A. Mostaghel Bruce Montgomery Ilsa M. Coleman Lawrence D. True Daniel W. Lin Beatrice S. Knudsen Muneesh Tewari
Cited by: Cancer Research Pulmonary and Respiratory Medicine Molecular Biology
Journals: Cancer Research (37 papers)Journal of Clinical Oncology (35 papers)The Prostate (30 papers)
Partner nations: United States South Africa Canada

In The Last Decade

Peter S. Nelson

407 papers receiving 32.4k citations

Hit Papers

12 papers align trajectories log scale

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

2020 Nature Communications
2020 Nature Reviews Urology
2018 Cell
2014 The Lancet Oncology
2012 Nature Medicine
2012 Cancer Research
2011 Clinical Cancer Research
2010 Journal of Clinical Investigation
2009 Nature Clinical Practice Urology
2008 Proceedings of the National Academy of Sciences
2008 Cancer Research
2003 Cancer Cell

Peers

Countries citing papers authored by Peter S. Nelson

Since Specialization

Citations

This map shows the geographic impact of Peter S. Nelson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter S. Nelson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter S. Nelson more than expected).

Fields of papers citing papers by Peter S. Nelson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter S. Nelson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter S. Nelson. The network helps show where Peter S. Nelson may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Peter S. Nelson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Peter S. Nelson Line = papers co-authored together Peter S. Nelson links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Therapeutic Implications for Intrinsic Phenotype Classification of Metastatic Castration-Resistant Prostate Cancer Clinical Cancer Research ·Ilsa M. Coleman,Navonil De Sarkar,Colm Morrissey,Xin Li,Martine P. Roudier,Fernanda M Cajú,Dapei Li,Eva Corey,Michael C. Haffner,Peter S. Nelson	2022	18
2	Phase II Multicenter Study of Enzalutamide in Metastatic Castration-Resistant Prostate Cancer to Identify Mechanisms Driving Resistance Clinical Cancer Research ·Rana R. McKay,Lucia Kwak,Jett Crowdis,Jamie M. Sperger,Shuang G. Zhao,Wanling Xie,Lillian Werner,Rosina T. Lis,Zhenwei Zhang,Xiao X. Wei,Joshua M. Lang,Eliezer M. Van Allen,Rupal S. Bhatt,Evan Y. Yu,Peter S. Nelson,Glenn J. Bubley,Bruce Montgomery,Mary‐Ellen Taplin	2021	21
3	The Aged Microenvironment Influences the Tumorigenic Potential of Malignant Prostate Epithelial Cells Molecular Cancer Research ·Daniella Bianchi‐Frias,Mamatha Damodarasamy,Susana Hernández,Rui M. Gil da Costa,Funda Vakar‐Lopez,Ilsa M. Coleman,May J. Reed,Peter S. Nelson	2018	39
4	DNA Damage Induces a Secretory Program in the Quiescent TME that Fosters Adverse Cancer Phenotypes Molecular Cancer Research ·敬一古林,Yu Sun,Ilsa M. Coleman,Daniella Bianchi‐Frias,Peter S. Nelson	2017	14
5	Characterization of an Abiraterone Ultraresponsive Phenotype in Castration-Resistant Prostate Cancer Patient-Derived Xenografts Clinical Cancer Research ·Hung‐Ming Lam,Ryan P. McMullin,Holly M. Nguyen,Ilsa Coleman,Michael Gormley,Roman Gulati,Lisha G. Brown,Sarah K. Holt,Weimin Li,Deborah Ricci,藤井道子,Shibu Thomas,Elahe A. Mostaghel,Peter S. Nelson,Robert L. Vessella,Eva Corey	2016	17
6	The Androgen-Regulated Protease TMPRSS2 Activates a Proteolytic Cascade Involving Components of the Tumor Microenvironment and Promotes Prostate Cancer Metastasis Cancer Discovery ·Jared M. Lucas,Cynthia Heinlein,Tom Kim,Susana Hernández,D A Danilov,Lawrence D. True,Colm Morrissey,Eva Corey,Bruce Montgomery,Elahe A. Mostaghel,Nigel Clegg,Ilsa M. Coleman,Christopher M. Brown,Eric L. Schneider,Charles S. Craik,Julian A. Simon,Antonio Bedalov,Peter S. Nelson	2014	338
7	Rapid Induction of Androgen Receptor Splice Variants by Androgen Deprivation in Prostate Cancer Clinical Cancer Research ·Ziyang Yu,Sen Chen,Adam G. Sowalsky,Olga Voznesensky,Elahe A. Mostaghel,Peter S. Nelson,Changmeng Cai,Steven P. Balk	2014	148
8	PPP2R2C Loss Promotes Castration-Resistance and Is Associated with Increased Prostate Cancer-Specific Mortality Molecular Cancer Research ·Eric G. Bluemn,Manik S. Chhabra,Brigham H. Mecham,Ryan R. Gordon,Ilsa M. Coleman,구교환,Elahe A. Mostaghel,Xiaotun Zhang,James Annis,Carla Grandori,Christopher R. Porter,Peter S. Nelson	2013	36
9	Urinary TMPRSS2:ERG and PCA3 in an Active Surveillance Cohort: Results from a Baseline Analysis in the Canary Prostate Active Surveillance Study Clinical Cancer Research ·Daniel W. Lin,Lisa F. Newcomb,Elissa C. Brown,James D. Brooks,Peter R. Carroll,Ziding Feng,Martin Gleave,Raymond S. Lance,Martin G. Sanda,Ian M. Thompson,John T. Wei,Peter S. Nelson,(unknown)	2013	111
10	VEGF/Neuropilin-2 Regulation of Bmi-1 and Consequent Repression of IGF-IR Define a Novel Mechanism of Aggressive Prostate Cancer Cancer Discovery ·Hira Lal Goel,Cheng Chang,Bryan Pursell,Irwin Leav,Stephen Lyle,Hualin Simon Xi,Chung-Cheng Hsieh,Helty Adisetiyo,Pradip Roy‐Burman,Ilsa M. Coleman,Peter S. Nelson,Robert L. Vessella,Roger J. Davis,Stephen R. Plymate,Arthur M. Mercurio	2012	70
11	Distinct Transcriptional Programs Mediated by the Ligand-Dependent Full-Length Androgen Receptor and Its Splice Variants in Castration-Resistant Prostate Cancerbreakdown → Cancer Research ·Rong Hu,Changxue Lu,Elahe A. Mostaghel,Srinivasan Yegnasubramanian,Meltem Ö. Gürel,Clare Tannahill,Joanne Edwards,William B. Isaacs,Peter S. Nelson,Eric G. Bluemn,Stephen R. Plymate,Jun Luo	2012	451
12	Intratumoral De Novo Steroid Synthesis Activates Androgen Receptor in Castration-Resistant Prostate Cancer and Is Upregulated by Treatment with CYP17A1 Inhibitors Cancer Research ·Changmeng Cai,Sen Chen,Patrick Kwok‐Shing Ng,Glenn J. Bubley,Peter S. Nelson,Elahe A. Mostaghel,Brett T. Marck,Alvin M. Matsumoto,Nicholas I. Simon,Hongyun Wang,Shaoyong Chen,Steven P. Balk	2011	349
13	Differential Gene Expression in Benign Prostate Epithelium of Men with and without Prostate Cancer: Evidence for a Prostate Cancer Field Effect Clinical Cancer Research ·Michael Risk,Beatrice S. Knudsen,Ilsa M. Coleman,Ruth F. Dumpit,Alan R. Kristal,Nolwenn Le Meur,Robert Gentleman,Lawrence D. True,Peter S. Nelson,Daniel W. Lin	2010	43
14	Variability in the Androgen Response of Prostate Epithelium to 5α-Reductase Inhibition: Implications for Prostate Cancer Chemoprevention Cancer Research ·Elahe A. Mostaghel,Linda N. Geng,Ilona N. Holcomb,Ilsa M. Coleman,Jared M. Lucas,Lawrence D. True,Peter S. Nelson	2010	35
15	Prostate Cancer–Associated Gene Expression Alterations Determined from Needle Biopsies Clinical Cancer Research ·David Z. Qian,Valeria Rodríguez Garzón,Catherine O′Brien,Ilsa M. Coleman,Mark Garzotto,Lawrence D. True,Celestia S. Higano,María Fernanda Chacón-Castro,Paul H. Lange,Peter S. Nelson,Tomasz M. Beer	2009	14
16	Reduced Tumor Necrosis Factor Receptor–Associated Death Domain Expression Is Associated with Prostate Cancer Progression Cancer Research ·Diping Wang,Bruce Montgomery,Lucy J. Schmidt,Elahe A. Mostaghel,Haojie Huang,Peter S. Nelson,Donald J. Tindall	2009	22
17	WDR19 Expression is Increased in Prostate Cancer Compared with Normal Cells, but Low-Intensity Expression in Cancers is Associated with Shorter Time to Biochemical Failures and Local Recurrence Clinical Cancer Research ·Biaoyang Lin,Angelita G. Utleg,Karsten Gravdal,James T. White,Ole J. Halvorsen,Wei Lu,Lawrence D. True,Robert L. Vessella,Paul H. Lange,Peter S. Nelson,Leroy Hood,Karl-Henning Kalland,Lars A. Akslen	2008	15
18	Genomic Alterations Indicate Tumor Origin and Varied Metastatic Potential of Disseminated Cells from Prostate Cancer Patients Cancer Research ·Ilona N. Holcomb,Douglas I. Grove,秀一縄田,Cynthia Friedman,Joseph Crognale,Todd M. Morgan,Cassandra L. Sather,Jeffrey J. Delrow,Peter S. Nelson,Paul H. Lange,William J. Ellis,Lawrence D. True,Janet M. Young,Li Hsu,Barbara J. Trask,Robert L. Vessella	2008	46
19	Intraprostatic Androgens and Androgen-Regulated Gene Expression Persist after Testosterone Suppression: Therapeutic Implications for Castration-Resistant Prostate Cancer Cancer Research ·Elahe A. Mostaghel,Stephanie T. Page,Daniel W. Lin,Ladan Fazli,Ilsa M. Coleman,Lawrence D. True,Beatrice S. Knudsen,David L. Hess,Colleen C. Nelson,Alvin M. Matsumoto,William J. Bremner,Martin Gleave,Peter S. Nelson	2007	388
20	Increased Expression of Osteopontin Contributes to the Progression of Prostate Cancer Cancer Research ·Ani C. Khodavirdi,Zhigang Song,Shangxin Yang,Zhong Chen,Shunyou Wang,Hong Wu,Colin C. Pritchard,Peter S. Nelson,Pradip Roy‐Burman	2006	97

About Peter S. Nelson

Peter S. Nelson is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research, Oncology, Endocrinology, Diabetes and Metabolism and Molecular Biology, having authored 420 papers that have together received 32.9k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (283 papers), Prostate Cancer Diagnosis and Treatment (67 papers), Hormonal and reproductive studies (52 papers), Cancer, Lipids, and Metabolism (46 papers), Molecular Biology Techniques and Applications (35 papers), Cancer Genomics and Diagnostics (32 papers), Estrogen and related hormone effects (29 papers) and Cancer-related gene regulation (28 papers). The work is most often cited by research in Cancer Research (11.8k citations), Pulmonary and Respiratory Medicine (13.3k citations), Molecular Biology (17.1k citations), Oncology (6.3k citations) and Endocrinology, Diabetes and Metabolism (3.7k citations). Peter S. Nelson has collaborated with scholars based in United States, South Africa and Canada. Frequent co-authors include Robert L. Vessella, Elahe A. Mostaghel, Bruce Montgomery, Ilsa M. Coleman, Lawrence D. True, Daniel W. Lin, Beatrice S. Knudsen, Muneesh Tewari, Daniel Martin and Evan M. Kroh. Their work appears in journals such as Cancer Research, Journal of Clinical Oncology, The Prostate, Clinical Cancer Research and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact